OTC · Solution · Sublingual
Lachesis Muta Venom, Silicon Dioxide, Sodium Chloride, Ranunculus Bulbosus, Aconitum Napellus, Activated Charcoal, Nitroglycerin, Oyster Shell Calcium Carbonate, Crude, Anemone Pratensis, Plantago Major, Arsenic Trioxide, And Magnesium Phosphate, Dibasic Trihydrate
Brands: D-112 · Lachesis Muta Venom + Silicon Dioxide + Sodium Chloride + Ranunculus Bulbosus + Aconitum Napellus + Activated Charcoal + Nitroglycerin + Oyster Shell Calcium Carbonate, Crude + Anemone Pratensis + Plantago Major + Arsenic Trioxide + Magnesium Phosphate, Dibasic Trihydrate
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages1
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| DNA Labs, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.
Pill